Literature DB >> 26724269

Executive function is affected in autism spectrum disorder, but does not correlate with intelligence.

Jessica Merchán-Naranjo1, Leticia Boada2, Ángel del Rey-Mejías3, María Mayoral2, Cloe Llorente2, Celso Arango2, Mara Parellada2.   

Abstract

INTRODUCTION: Studies of executive function in autism spectrum disorder without intellectual disability (ASD-WID) patients are contradictory. We assessed a wide range of executive functioning cognitive domains in a sample of children and adolescents with ASD-WID and compared them with age-, sex-, and intelligence quotient (IQ)-matched healthy controls.
METHODS: Twenty-four ASD-WID patients (mean age 12.8±2.5 years; 23 males; mean IQ 99.20±18.81) and 32 healthy controls (mean age 12.9±2.7 years; 30 males; mean IQ 106.81±11.02) were recruited.
RESULTS: Statistically significant differences were found in all cognitive domains assessed, with better performance by the healthy control group: attention (U=185.0; P=.0005; D=0.90), working memory (T51.48=2.597; P=.006; D=0.72), mental flexibility (U=236.0; P=.007; D=0.67), inhibitory control (U=210.0; P=.002; D=0.71), and problem solving (U=261.0; P=0.021; D=0.62). These statistically significant differences were also found after controlling for IQ.
CONCLUSION: Children and adolescents with ASD-WID have difficulties transforming and mentally manipulating verbal information, longer response latency, attention problems (difficulty set shifting), trouble with automatic response inhibition and problem solving, despite having normal IQ. Considering the low executive functioning profile found in those patients, we recommend a comprehensive intervention including work on non-social problems related to executive cognitive difficulties.
Copyright © 2015 SEP y SEPB. Published by Elsevier España. All rights reserved.

Entities:  

Keywords:  Asperger syndrome; Autismo de alto funcionamiento; Evaluación neuropsicológica; Executive function; Funcionamiento ejecutivo; High functioning autism; Inteligencia; Intelligence; Neuropsychological assessment; Síndrome de Asperger

Mesh:

Year:  2015        PMID: 26724269     DOI: 10.1016/j.rpsm.2015.10.005

Source DB:  PubMed          Journal:  Rev Psiquiatr Salud Ment        ISSN: 1888-9891            Impact factor:   3.318


  6 in total

1.  Executive Functions in Children and Adolescents with Autism Spectrum Disorder in Family and School Environment.

Authors:  Ana Gentil-Gutiérrez; Mirian Santamaría-Peláez; Luis A Mínguez-Mínguez; Jessica Fernández-Solana; Jerónimo J González-Bernal; Josefa González-Santos; Ana I Obregón-Cuesta
Journal:  Int J Environ Res Public Health       Date:  2022-06-26       Impact factor: 4.614

2.  Inability to activate Rac1-dependent forgetting contributes to behavioral inflexibility in mutants of multiple autism-risk genes.

Authors:  Tao Dong; Jing He; Shiqing Wang; Lianzhang Wang; Yuqi Cheng; Yi Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-22       Impact factor: 11.205

3.  P300 amplitude and latency in autism spectrum disorder: a meta-analysis.

Authors:  Tingkai Cui; Peizhong Peter Wang; Shengxin Liu; Xin Zhang
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-06-14       Impact factor: 4.785

4.  Valproic acid treated female Long-Evans rats are impaired on attentional set-shifting.

Authors:  Zach E McKinnell; Tessa Maze; Alejandro Ramos; Brandon Challans; Bethany Plakke
Journal:  Behav Brain Res       Date:  2020-10-11       Impact factor: 3.332

5.  Metacognitive Aspects of Executive Function Are Highly Associated with Social Functioning on Parent-Rated Measures in Children with Autism Spectrum Disorder.

Authors:  Tonje Torske; Terje Nærland; Merete G Øie; Nina Stenberg; Ole A Andreassen
Journal:  Front Behav Neurosci       Date:  2018-01-10       Impact factor: 3.558

6.  Executive functioning, adaptive skills, emotional and behavioral profile: A comparison between autism spectrum disorder and phenylketonuria.

Authors:  Barbara Trimarco; Filippo Manti; Francesca Nardecchia; Sergio Melogno; Mara Testa; Giovanni Meledandri; Claudia Carducci; Roberta Penge; Vincenzo Leuzzi
Journal:  Mol Genet Metab Rep       Date:  2020-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.